Healthcare provider profile · identity verified

Daniel Le, MD

Internal Medicine · MONROE, WI · NPI 1972524676

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1242	308
Lisinopril	Lisinopril	575	155
Levothyroxine Sodium	Levothyroxine Sodium	541	109
Amlodipine Besylate	Amlodipine Besylate	472	109
Furosemide	Furosemide	406	91
Gabapentin	Gabapentin	382	68
Omeprazole	Omeprazole	368	92
Eliquis	Apixaban	349	54
Metformin Hcl Er	Metformin Hcl	347	91
Jardiance	Empagliflozin	339	61
Hydrochlorothiazide	Hydrochlorothiazide	330	91
Metoprolol Succinate	Metoprolol Succinate	248	66
Tamsulosin Hcl	Tamsulosin Hcl	243	64
Metformin Hcl	Metformin Hcl	241	54
Warfarin Sodium	Warfarin Sodium	230	55
Spironolactone	Spironolactone	227	58
Ozempic	Semaglutide	211	33
Simvastatin	Simvastatin	211	53
Losartan Potassium	Losartan Potassium	209	59
Metoprolol Tartrate	Metoprolol Tartrate	208	46
Duloxetine Hcl	Duloxetine Hcl	205	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	205	46
Irbesartan	Irbesartan	196	55
Allopurinol	Allopurinol	193	49
Rosuvastatin Calcium	Rosuvastatin Calcium	187	49
Carvedilol	Carvedilol	186	45
Mirtazapine	Mirtazapine	154	28
Pantoprazole Sodium	Pantoprazole Sodium	154	38
Trulicity	Dulaglutide	140	25
Sertraline Hcl	Sertraline Hcl	136	30
Potassium Chloride	Potassium Chloride	134	36
Escitalopram Oxalate	Escitalopram Oxalate	131	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	124	33
Albuterol Sulfate Hfa	Albuterol Sulfate	115	34
Atenolol	Atenolol	114	32
Glipizide Er	Glipizide	107	25
Lorazepam	Lorazepam	101	19
Glipizide	Glipizide	94	26
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	87	18
Tramadol Hcl	Tramadol Hcl	85	19
Celecoxib	Celecoxib	83	23
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	78	20
Fluticasone Propionate	Fluticasone Propionate	76	19
Pravastatin Sodium	Pravastatin Sodium	76	19
Xarelto	Rivaroxaban	75	15
Alendronate Sodium	Alendronate Sodium	74	16
Famotidine	Famotidine	74	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	20
Montelukast Sodium	Montelukast Sodium	73	16
Farxiga	Dapagliflozin Propanediol	72	15
Clopidogrel	Clopidogrel Bisulfate	70	14
Mounjaro	Tirzepatide	69	12
Alprazolam	Alprazolam	66	12
Paroxetine Hcl	Paroxetine Hcl	64	16
Ezetimibe	Ezetimibe	63	11
Levetiracetam	Levetiracetam	61	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	16
Trazodone Hcl	Trazodone Hcl	61	16
Ropinirole Hcl	Ropinirole Hcl	60	suppressed
Tizanidine Hcl	Tizanidine Hcl	60	suppressed
Memantine Hcl	Memantine Hcl	59	suppressed
Buspirone Hcl	Buspirone Hcl	55	11
Topiramate	Topiramate	55	12
Clonidine Hcl	Clonidine Hcl	54	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	54	12
Finasteride	Finasteride	53	13
Oxycodone Hcl	Oxycodone Hcl	53	14
Lovastatin	Lovastatin	52	11
Nifedipine Er	Nifedipine	52	suppressed
Prednisone	Prednisone	52	24
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	49	suppressed
Divalproex Sodium	Divalproex Sodium	48	suppressed
Humalog Kwikpen U-100	Insulin Lispro	48	14
Benazepril Hcl	Benazepril Hcl	46	12
Venlafaxine Hcl	Venlafaxine Hcl	46	suppressed
Baclofen	Baclofen	44	suppressed
Breo Ellipta	Fluticasone/Vilanterol	43	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	43	suppressed
Meloxicam	Meloxicam	42	14
Arnuity Ellipta	Fluticasone Furoate	41	suppressed
Donepezil Hcl	Donepezil Hcl	40	suppressed
Morphine Sulfate Er	Morphine Sulfate	40	suppressed
Propranolol Hcl	Propranolol Hcl	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Pregabalin	Pregabalin	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	13
Insulin Lispro Kwikpen U-100	Insulin Lispro	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	34	suppressed
Valsartan	Valsartan	34	suppressed
Myrbetriq	Mirabegron	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	15
Aripiprazole	Aripiprazole	32	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Novolog Flexpen	Insulin Aspart	31	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Chlorthalidone	Chlorthalidone	28	12
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Latanoprost	Latanoprost	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Lactulose	Lactulose	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	suppressed
Nystatin	Nystatin	27	18
Fiasp Flextouch	Insulin Aspart (Niacinamide)	26	suppressed
Bumetanide	Bumetanide	25	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	25	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	24	suppressed
Cefuroxime	Cefuroxime Axetil	23	17
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Estradiol	Estradiol	23	suppressed
Clozapine	Clozapine	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Diazepam	Diazepam	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Sulfasalazine	Sulfasalazine	21	suppressed
Glimepiride	Glimepiride	20	suppressed
Keppra	Levetiracetam	20	suppressed
Methadone Hcl	Methadone Hcl	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Morphine Sulfate	Morphine Sulfate	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Premarin	Estrogens, Conjugated	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	19	18
Insulin Aspart Flexpen	Insulin Aspart	19	suppressed
Letrozole	Letrozole	19	suppressed
Mesalamine	Mesalamine	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Albuterol Sulfate	Albuterol Sulfate	18	suppressed
Cephalexin	Cephalexin	18	11
Colchicine	Colchicine	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Fentanyl	Fentanyl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Linzess	Linaclotide	18	suppressed
Rexulti	Brexpiprazole	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Naproxen	Naproxen	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Torsemide	Torsemide	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Dayvigo	Lemborexant	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	13	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Lyrica	Pregabalin	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error